CMH Wealth Management
PFE icon

CMH Wealth Management’s Pfizer PFE Stock Holding History

CMH Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$558K Sell
19,554
-36,460
-65% -$970K 0.08% 86
2026
Q2 		$1.35M Sell
56,014
-13,828
-20% -$362K 0.21% 76
2026
Q1 		$1.96M Buy
+69,842
New +$1.86M 0.34% 65
2019
Q1 		– Sell
-327
Closed -$14K – 57
2018
Q4 		$14K Buy
+327
New +$13.6K 0.01% 59

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

CMH Wealth Management's PFE Position: Q3 2026 in Review

CMH Wealth Management reduced its Pfizer (PFE) stake by 65% in Q3 2026, selling an estimated $970K and leaving 19,554 shares worth $558K. The position accounts for 0.08% of the portfolio, ranked #86.

CMH Wealth Management first reported a position in PFE in Q4 2018 and has held it in 4 quarters since. The position peaked at $1.96M in Q1 2026. 811 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • CMH Wealth Management held 19,554 shares of Pfizer worth $558K as of Q3 2026.
  • CMH Wealth Management sold 36,460 Pfizer shares in Q3 2026, an estimated $970K.
  • Pfizer made up 0.08% of CMH Wealth Management's portfolio in Q3 2026, its #86 holding.
  • CMH Wealth Management first reported a position in Pfizer in Q4 2018 and has held it in 4 quarters since.
  • CMH Wealth Management's Pfizer position peaked at $1.96M in Q1 2026.
  • 811 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on CMH Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.